Adicet Bio
ACET
ACET
86 hedge funds and large institutions have $77.4M invested in Adicet Bio in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
56% less capital invested
Capital invested by funds: $177M → $77.4M (-$99.2M)
84% less call options, than puts
Call options by funds: $7K | Put options by funds: $44K
Holders
86
Holding in Top 10
–
Calls
$7K
Puts
$44K
Top Buyers
| 1 | +$3.06M | |
| 2 | +$2.19M | |
| 3 | +$882K | |
| 4 |
D.E. Shaw & Co
New York
|
+$617K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$566K |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$3.73M | |
| 3 | -$3.57M | |
| 4 |
CC
Commodore Capital
New York
|
-$3.23M |
| 5 |
BlackRock
New York
|
-$2.85M |